How to buy shares of Eledon Pharmaceuticals (ELDN) – I explain how

eledon pharmaceuticals

Eledon Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, is focused on developing medicines for patients living with autoimmune diseases and amyotrophic lateral sclerosis (ALS) who require an organ or cell transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target the CD40 ligand which is a molecule expressed on the surface of T cells of the human immune system, which is in Phase 2a clinical trials for the treatment of ALS. , and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. Eledon Pharmaceuticals, Inc. has a collaboration agreement with CareDx, Inc. The company was previously known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals,

How to buy shares of Eledon Pharmaceuticals (ELDN) – I explain how

Would you like to buy Eledon Pharmaceuticals (ELDN) shares on Nasdaq risk-free and using an officially regulated broker? Would you like to be able to make your monthly savings profitable and get interest on the stock market? With this guide I am going to show you how easy it is to register an account with DEGIRO , a regulated German investment broker with very low commissions, and how you can get your first shares of Eledon Pharmaceuticals, Inc. (ELDN) (ELDN) quickly. and easy.

The process is very intuitive :

  • The first step is that we will register in Degiro, a broker platform in which we will invest in shares of the company Eledon Pharmaceuticals, Inc. (ELDN), (ELDN).
  • In 2nd place we will add capital to execute our 1st investment.
  • Once we have the funds, what we are going to do is locate the company Eledon Pharmaceuticals using the Ticker, which is ELDN.
  • Finally, we only have to indicate the number of shares to buy, purchase value and type of order.

This summary may have been somewhat simple for you, so I am going to explain the process with images of each part:

How to open your Degiro account

To start we are going to register in Degiro from this link :

buy shares of Eledon Pharmaceuticals, Inc. (ELDN)

It will ask us for an email, a username and a PIN code to access, and immediately we must continue from the link that they have sent us by mail.

DEGIRO will then ask us for the necessary information in order to confirm our document . We will need to have on hand our passport number, ID or driving license, your telephone number and the number of the bank account that we are going to apply to make our first deposit in IBAN format. If you do not know what this format is like, you can review this simple guide article that we have created at Educacep.es .

stock Eledon Pharmaceuticals

Once our account is confirmed we will have to put money from the Enter / Withdraw tab. We will be able to make a bank transfer that will take 1 to 2 days, or proceed to make the deposit quickly with Sofort, a truly secure and 100% reliable payment gateway.

bank transfer Eledon Pharmaceuticals

How to buy Eledon Pharmaceuticals (ELDN) shares through Degiro

Once we have the money we will be able to acquire our first share. You can go to the Place Order button in the right corner or use the DeGiro search engine and write the ticker. In the following image you will see that I have put the Amazon Ticker but in your case you must put (ELDN), the Eledon Pharmaceuticals ticker. As we are talking about an action, we will detect that the related tickers are listed and there we will see Eledon Pharmaceuticals. What is key is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on Nasdaq (NDQ) and in your case Eledon Pharmaceuticals, Inc. (ELDN) is listed on Nasdaq. This step is essential so make no mistake.

American stock market today Eledon Pharmaceuticals

At the time of developing the order we must pay attention to what I will explain to you . We will be able to place a limit or market order. You think you want to buy a share of Eledon Pharmaceuticals, but its true price is too high. With the limit order we will put the value at which we want to make the acquisition and until there are no shares selling at that value, the purchase operation of the share will not be executed. With a market order Degiro will buy the number of shares we have proposed at the actual selling price, which will be very close to today’s listed price.

limited order which is Eledon Pharmaceuticals, Inc. (ELDN)

In any situation it is very convenient that you look at the type of alignment: fixed or of the day . To give an example, in Spain, the stock market is in the morning and until 1:00 p.m., and in the United States it coincides with the afternoon schedule in Spain. If the order is permanent, it will be there until it is executed, but if you choose the «of the day» option, at the time the stock market session ends, if it has not been executed, it will be deleted from your Activity history – Orders in Pending status.

I want this short post to be useful for you to invest in Eledon Pharmaceuticals. Until next time.

  Company information
  • Address of Eledon Pharmaceuticals, Inc. (ELDN): 19900 MacArthur Boulevard, Suite 550 Irvine, CA 92612 United States 949 238 8090 – Website: http://eledon.com
  • Ticker: ELDN
  • Industry: Unknown
  • Industry: Biotechnology
  • Number of employees: 10
  • Listed market: Nasdaq

key executives

Name Title Salary exercised Year of birth
David-Alexander C. Gros, MD CEO and non-independent director 242.43k N/A 1972
Dr. Steven N. Perrin Ph.D. Pres, scientific director and non-independent director 419.39k N/A 1966
Mr. Gregory J. Flesher Consultant 1.8M N/A 1970
Mr Paul Sean Little Chief Financial Officer and Accountant N/A N/A 1965
Mr. Bryan E. Smith JD General Counsel, Sec. Corp. & Chief Compliance Officer N/A N/A 1980
Dr. Jeffrey D. Bornstein Medical director N/A N/A N/A
Dr. David Hovland Ph.D. Regulatory Director N/A N/A N/A

Recent events of :

Recent Events: November 12, 2021. Filed Complete: 10-Q: Quarterly Report November 12, 2021. Filed Complete: 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits August 12, 2021. Filed Complete: 10-Q: Quarterly Report August 12, 2021. Filed Complete: 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits August 02, 2021. Filed Complete: 8-K: Change of Directors or Principal OfficersShow All Events